Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study*

By Feuerhake Cord   Buchholz Patricia   Kimmich Friedemann  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 1037-1043

Informa Healthcare

Access to resources Recommend Favorite

24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma

By Feldman Robert M.   Stewart Robert H.   Stewart William C.   Jia Gang   Smugar Steven S.   Galet Vincent A.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2403-2412

Informa Healthcare

Access to resources Recommend Favorite

Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%–timolol 0.5% therapy

By Motolko Michael A.  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2663-2667

Informa Healthcare

Access to resources Recommend Favorite

A comparison of the safety and intraocular pressure lowering of bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in patients with open-angle glaucoma

By Martinez Antonio   Sanchez Manuel  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1025-1032

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension

By Suzuki Emilio Rintaro   Meirelles Franklin Luciana   da Silva Luciano José Basilio   Figueiredo Carlos R. L.   Agostini Netto Joao   Batista Wagner Duarte  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1799-1805

Informa Healthcare

Access to resources Recommend Favorite